These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11356104)

  • 1. Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.
    Pak Y; Enyedy IJ; Varady J; Kung JW; Lorenzo PS; Blumberg PM; Wang S
    J Med Chem; 2001 May; 44(11):1690-701. PubMed ID: 11356104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB; Enyedy IJ; Qiao L; Zhao L; Ma D; Pearce LL; Lorenzo PS; Stone JC; Blumberg PM; Wang S; Kozikowski AP
    J Med Chem; 2002 Feb; 45(4):853-60. PubMed ID: 11831896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
    Wang S; Liu M; Lewin NE; Lorenzo PS; Bhattacharrya D; Qiao L; Kozikowski AP; Blumberg PM
    J Med Chem; 1999 Sep; 42(18):3436-46. PubMed ID: 10479277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.
    Wang QJ; Fang TW; Nacro K; Marquez VE; Wang S; Blumberg PM
    J Biol Chem; 2001 Jun; 276(22):19580-7. PubMed ID: 11278612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Bögi K; Lorenzo PS; Szállási Z; Acs P; Wagner GS; Blumberg PM
    Cancer Res; 1998 Apr; 58(7):1423-8. PubMed ID: 9537243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
    Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
    J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chemical characteristics of the first and the second cysteine-rich domains of protein kinase C gamma.
    Irie K; Yanai Y; Oie K; Ishizawa J; Nakagawa Y; Ohigashi H; Wender PA; Kikkawa U
    Bioorg Med Chem; 1997 Aug; 5(8):1725-37. PubMed ID: 9313873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.
    Pu Y; Peach ML; Garfield SH; Wincovitch S; Marquez VE; Blumberg PM
    J Biol Chem; 2006 Nov; 281(44):33773-88. PubMed ID: 16950780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C ligands based on tetrahydrofuran templates containing a new set of phorbol ester pharmacophores.
    Lee J; Kang JH; Lee SY; Han KC; Torres CM; Bhattacharyya DK; Blumberg PM; Marquez VE
    J Med Chem; 1999 Oct; 42(20):4129-39. PubMed ID: 10514283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J; Deng F; Li J; Wang QJ
    Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis.
    Kazanietz MG; Wang S; Milne GW; Lewin NE; Liu HL; Blumberg PM
    J Biol Chem; 1995 Sep; 270(37):21852-9. PubMed ID: 7665608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.
    Roaten JB; Kazanietz MG; Sweatman TW; Lothstein L; Israel M; Parrill AL
    J Med Chem; 2001 Mar; 44(7):1028-34. PubMed ID: 11297449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
    Nacro K; Bienfait B; Lee J; Han KC; Kang JH; Benzaria S; Lewin NE; Bhattacharyya DK; Blumberg PM; Marquez VE
    J Med Chem; 2000 Mar; 43(5):921-44. PubMed ID: 10715158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of phorbol ester binding to protein kinase C isotypes.
    Dimitrijević SM; Ryves WJ; Parker PJ; Evans FJ
    Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
    Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains.
    Ananthanarayanan B; Stahelin RV; Digman MA; Cho W
    J Biol Chem; 2003 Nov; 278(47):46886-94. PubMed ID: 12954613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.